SAT0059 Baseline Interleukin-17A PREDICT Treatment Response to TOCILIZUMAB and Disease-Modifying Antirheumatic Drugs Therapy

Lee, S.J.; Yoon, M.J.; Joo, S.H.; Park, W.; Park, S.H.; Shim, S.C.; Baek, H.J.; Yoo, D.-H.; Kim, H.A.; Lee, S.K.; Lee, Y.J.; Park, Y.E.; Cha, H.-S.; Choi, I.A.; Lee, E.Y.; Lee, E.B.; Song, Y.W.

期刊名称Annals of the Rheumatic Diseases
作者Lee, S.J.; Yoon, M.J.; Joo, S.H.; Park, W.; Park, S.H.; Shim, S.C.; Baek, H.J.; Yoo, D.-H.; Kim, H.A.; Lee, S.K.; Lee, Y.J.; Park, Y.E.; Cha, H.-S.; Choi, I.A.; Lee, E.Y.; Lee, E.B.; Song, Y.W.
卷第73卷
印刷ISSN0003-4967
电子ISSN1468-2060
文件大小174.95KB
发表时间2014-06
DOI10.1136/annrheumdis-2014-eular.5095
页码610-611

发现好书期刊，享受阅读乐趣

SAT0059 Baseline Interleukin-17A PREDICT Treatment Response to TOCILIZUMAB and Disease-Modifying Antirheumatic Drugs Therapy